This publication summarizes the evidence for the effectiveness of interventions for secondary prevention of coronary heart disease (CHD) and cerebrovascular disease (CeVD). A commentary on the evidence for cardiovascular prevention in peripheral vascular disease and diabetes is also included. Each review of evidence is followed by a short summary of clinical recommendations for secondary prevention. A review of other considerations influencing policy-makers in the implementation of secondary prevention strategies including health economics follows. Finally, the book identifies areas in which research is needed to improve secondary prevention of CVD in low- and middle-income populations. This publication is intended for practicing physicians responsible for the care of patients with established cardiovascular disease (CVD) - specifically CHD and CeVD - in low- and middle-income populations and countries. The aim is to provide general guidance about the effectiveness - or lack of effectiveness - of specific interventions, both pharmacological and non-pharmacological. In addition, the information will help a wide range of health professionals concerned with individual and community care and will provide guidance to health policy-makers about the broader issues pertaining to implementation of interventions in low- and middle-income populations.
Author(s): Organizacion Panamericana de la Salud
Year: 2003
Language: Spanish
Pages: 122
Preliminaries......Page 1
Contenido......Page 3
1. Antecedentes......Page 11
2. Alcance y propósito de las directrices para la prevención secundaria de la ECV......Page 15
3. Método de formulación de las recomendaciones......Page 17
4. Eficacia de las intervenciones en la prevención secundaria de la ECV......Page 19
5. Resumen de las intervenciones eficaces en la prevención secundaria de la ECV......Page 67
6. Repercusiones para las políticas de salud......Page 75
7. Repercusiones para la investigación......Page 83
8. Cuadros......Page 87
9. Figuras......Page 95
10. Referencias......Page 99
11. Grupo de expertos: participantes en la consulta de la OMS......Page 115